Holen Sie sich die Stockscreener-App
13.30
0.53%
0.07
Schlusskurs vom Vortag:
$13.23
Offen:
$13.27
24-Stunden-Volumen:
1.32M
Relative Volume:
0.98
Marktkapitalisierung:
$993.79M
Einnahmen:
$255.87M
Nettoeinkommen (Verlust:
$-103.27M
KGV:
-9.4266
EPS:
-1.4109
Netto-Cashflow:
$12.46M
1W Leistung:
+11.30%
1M Leistung:
+7.69%
6M Leistung:
-19.25%
1J Leistung:
-37.32%
1-Tages-Spanne:
$13.12
$13.65
1-Wochen-Bereich:
$11.75
$13.65
52-Wochen-Spanne:
$10.95
$27.63
Schrodinger Inc Stock (SDGR) Company Profile
Firmenname
Schrodinger Inc
Sektor
Branche
Telefon
503-299-1150
Adresse
1540 BROADWAY, NEW YORK, NY
Compare SDGR vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SDGR
Schrodinger Inc
|
13.30 | 988.56M | 255.87M | -103.27M | 12.46M | -1.4109 |
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-15 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-30 | Eingeleitet | Goldman | Neutral |
| 2025-08-15 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-08-14 | Eingeleitet | Barclays | Overweight |
| 2025-07-03 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-07-02 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-05 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-12-19 | Eingeleitet | Goldman | Neutral |
| 2022-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-11 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-10-13 | Eingeleitet | Berenberg | Buy |
| 2021-09-01 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-25 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-23 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-10-12 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-02 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-02 | Eingeleitet | Jefferies | Hold |
| 2020-03-02 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Schrodinger Inc Aktie (SDGR) Neueste Nachrichten
How The Schrödinger (SDGR) Investment Story Is Shifting As Analysts Reset Price Targets - Yahoo Finance
Stephens Investment Management Group LLC's Schrodinger Inc(SDGR) Holding History - GuruFocus
Schrodinger (SDGR) Issues Stock Options and RSUs to New Employees - GuruFocus
Schrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - pharmiweb.com
Schrodinger reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Schrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Schrodinger Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Schrödinger Announces Leadership Change Amid Maintained 2026 Outlook - TipRanks
My Top 3 Biotech Stocks for May 2026 - Yahoo Finance
My Top 3 Biotech Stocks for May 2026 - The Motley Fool
Schrödinger Balances Growth and Losses in Earnings Call - TipRanks
SDGR: Improved funding and tech adoption are accelerating drug discovery and portfolio growth - TradingView
Schrodinger Inc at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Schrodinger : SDGR - 24/7 Wall St.
Schrodinger stock (US80655G1067): AI-powered drug discovery story after latest earnings - AD HOC NEWS
Rubric Capital and David Rosen disclose 9.28% position in Schrodinger (SDGR) - Stock Titan
(SDGR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
SDGR Price Today: Schrodinger, Inc. Stock Price, Quote & Chart | MEXC - MEXC
SDGR Maintained by Morgan Stanley -- Price Target Lowered to $17 - GuruFocus
Morgan Stanley Maintains Schrodinger(SDGR.US) With Hold Rating, Cuts Target Price to $17 - Moomoo
Morgan Stanley Lowers Price Target on Schrodinger to $17 From $19, Keeps Equalweight Rating - marketscreener.com
Schrodinger, Inc. Stock 12‑Month Price Target Cut to $20.88, Implies 64% Upside - TradingView
SDGR: Hosted revenue jumps to 34% as broad-based growth and new products drive positive momentum - TradingView
SDGR Stock Price, Quote & Chart | SCHRODINGER INC (NASDAQ:SDGR) - ChartMill
TradingKey - TradingKey
UBS Group AG Buys 489,059 Shares of Schrodinger, Inc. $SDGR - MarketBeat
Number of shareholders of Schrodinger, Inc. – LS:A2PY7M - TradingView
Schrodinger Inc stock (US80655G1067): Q1 loss and revenue miss weigh on shares - AD HOC NEWS
Analysts Have Lowered Expectations For Schrödinger, Inc. (NASDAQ:SDGR) After Its Latest Results - simplywall.st
Earnings Update: Schrödinger, Inc. (NASDAQ:SDGR) Just Reported And Analysts Are Trimming Their Forecasts - Yahoo Finance
BofA Securities Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
Schrödinger : Schrödinger Corporate Presentation - marketscreener.com
Analysts Offer Insights on Healthcare Companies: QuidelOrtho (QDEL), Contineum Therapeutics, Inc. Class A (CTNM) and Schrodinger (SDGR) - The Globe and Mail
MSN Money - MSN
Evan Seigerman Reiterates Buy on Schrödinger as Software Expansion and Partnered Successes Strengthen Long-Term Growth Outlook - TipRanks
BMO Capital Maintains Schrodinger(SDGR.US) With Buy Rating, Cuts Target Price to $24 - Moomoo
A Look At Schrödinger (NasdaqGS:SDGR) Valuation After Q1 Earnings And Hosted AI Software Push - Yahoo Finance
Schrödinger, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Schrödinger, Inc. (NASDAQ:SDGR) Q1 2026 Earnings Call Transcript - Insider Monkey
Craig-Hallum Maintains Schrodinger(SDGR.US) With Buy Rating - Moomoo
Schrödinger Reports First Quarter 2026 Financial Results - BioSpace
Schrödinger, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:SDGR) 2026-05-06 - Seeking Alpha
Schrödinger Q1 2026 slides: AI platform advances amid transition By Investing.com - Investing.com Nigeria
Schrodinger, Inc. (SDGR) Reports Q1 Loss, Misses Revenue Estimates - MSN
Schrodinger Q1 Earnings Call Highlights - Yahoo Finance
TD Cowen Maintains Schrodinger(SDGR.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Schrödinger outlines $218M-$228M 2026 ACV outlook with focus on hosted transition and Bunsen early access release - MSN
Schrödinger Earnings Call: Growth Now, Profits Later - TipRanks
Schrödinger Inc (NASDAQ:SDGR) Q1 2026 Earnings: Revenue Beat Fails to Offset Loss Miss, Stock Slides - ChartMill
Schrödinger (SDGR) Q1 2026 Earnings Transcript - AOL.com
SDGR Financials: Income Statement, Balance Sheet & Cash Flow | Schrodinger, Inc. - Stock Titan
Finanzdaten der Schrodinger Inc-Aktie (SDGR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Schrodinger Inc-Aktie (SDGR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Farid Ramy | President & CEO |
Apr 17 '26 |
Option Exercise |
3.07 |
117,527 |
360,808 |
405,351 |
| Farid Ramy | President & CEO |
Apr 16 '26 |
Option Exercise |
3.07 |
43,000 |
132,010 |
373,824 |
| Farid Ramy | President & CEO |
Apr 16 '26 |
Sale |
12.33 |
43,000 |
530,233 |
330,824 |
| Farid Ramy | President & CEO |
Apr 17 '26 |
Sale |
12.21 |
43,000 |
524,944 |
330,824 |
| Jain Rachit | EVP & CFO |
Apr 16 '26 |
Sale |
12.75 |
844 |
10,758 |
51,752 |
0.66%
4.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):